Jo Varshney, PhD, DVM, discusses how VeriSIM Life’s innovative approach leverages artificial intelligence and multispecies data.
Jo Varshney, PhD, DVM
Advertisement
Jo Varshney, PhD, DVM, CEO and founder of VeriSIM Life.
Articles by Jo Varshney, PhD, DVM
Jo Varshney, PhD, DVM, discusses how artificial intelligence–powered simulations speed drug approvals and reduce clinical trial risk.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
2
ATTR-CM Incidence, Prevalence Rose Sharply in the US
3
Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC
4
FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance
5